Signant Health's eCOA/ePRO solution, called TrialMax®, is a proven eCOA platform that leverages 20 years of scientific, operational, and regulatory experience.
At Alector, our mission is to develop therapies that empower the immune system to cure neurodegeneration. Our team is solely focused on developing cures for some of the most challenging diseases facing our society. We are supported in this mission
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for